Now Enrolling
We Are Currently Seeking Qualified Participants in the Following Clinical Trials:
- Asthma for Adolescents and Adults
A
26 Week Randomized, Double-Blinded, Active Controlled Study Comparing
the Safety of Mometasone Furoate/Formoterol Ramarate MDI Fixed Dose
Combination Versus Mometasone Furoate MDI Monotherapy in Adolescents and
Adults with Persistent Asthma
- Diabetes for Patients on Insulin or in Combination with Metformin
A
Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled
Clinical Trial to Study the Safety and Efficacy of the Addition of
Sitagliptin (MK-431) in Patients with Type 2 Diabetes Mellitus who have
inadequate Glycemic Control on Insulin Alone or in Combination with
Metformin
- Diabetes for patients uncontrolled on at least 2 medications
A
comparison of LY2605541 versus Insulin Glargine as Basal Insulin
Treatment in Combination with Oral Anti=Hyperglycemia Medications in
Insulin-Naiive Patients with Type 2 Diabetes Mellitus: A Double=Blind,
Randomized Study The IMAGINE 2 Study
Long-Term Allopurinol Safety Study Evaluating Outcomes in Gout Patients
A randomized, double-blind, placebo-controlled, event-driven trial of quarterly subcutaneous canakinumab in the
prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with elevated
hsCRP
A
randomized, double-blind, active-controlled study of canakinumab
(ACZ885) pre-filled syringes or reconstituted lyophilizate versus
triamcinolone acetonide for treating acute gouty arthritis flares in
frequently flaring patients
A
Phase llb Randomized, Placebo- and Active Comparator
(Tolterodine)-Controlled, 2 Part Clinical Study of the Efficacy and
Safety of MK-4618 in Patients with Overactive Bladder